Document Detail

Corticosteroids for treating hypotension in preterm infants.
MedLine Citation:
PMID:  22161379     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Systemic hypotension is a relatively common complication of preterm birth and is associated with periventricular haemorrhage, periventricular white matter injury and adverse neurodevelopmental outcome. Corticosteroid treatment has been used as an alternative or an adjunct to conventional treatment with volume expansion and vasopressor/inotropic therapy.
OBJECTIVES: To determine the effectiveness and safety of corticosteroids used either as primary treatment of hypotension or for the treatment of refractory hypotension in preterm infants.
SEARCH METHODS: Randomized or quasi-randomised controlled trials were identified by searching the Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library, Issue 2, 2011), MEDLINE (1996 to Jan 2011), EMBASE (1974 to Jan 2011), CINAHL (1981 to 2011), reference lists of published papers and abstracts from the Pediatric Academic Societies and the European Society for Pediatric Research meetings published in Pediatric Research (1995 to 2011).
SELECTION CRITERIA: We included all randomised or quasi-randomised controlled trials investigating the effect of corticosteroid therapy in the treatment of hypotension in preterm infants (< 37 weeks gestation) less than 28 days old. Studies using corticosteroids as primary treatment were included as well as studies using corticosteroids in babies with hypotension resistant to inotropes/pressors and volume therapy. We included studies comparing oral/intravenous corticosteroids with placebo, other drugs used for providing cardiovascular support or no therapy in this review.
DATA COLLECTION AND ANALYSIS: Methodological quality of eligible studies was assessed according to the methods used for minimising selection bias, performance bias, attrition bias and detection bias. Studies that evaluated corticosteroids (1) as primary treatment for hypotension or (2) for refractory hypotension unresponsive to prior use of inotropes/pressors and volume therapy, were analysed using separate comparisons. Data were analysed using the standard methods of the Neonatal Review Group using Rev Man 5.1.2. Treatment effect was analysed using relative risk, risk reduction, number needed to treat for categorical outcomes and weighted mean difference for outcomes measured on a continuous scale, with 95% confidence intervals.
MAIN RESULTS: Four studies were included in this review enrolling a total of 123 babies. In one study, persistent hypotension was more common in hydrocortisone treated infants as compared to those who received dopamine as primary treatment for hypotension (RR 8.2, 95% CI 0.47 to 142.6; RD 0.19, 95% CI 0.01 to 0.37). In two studies comparing steroid versus placebo, persistent hypotension (defined as a continuing need for inotrope infusion) was less common in steroid treated infants as compared to controls who received placebo for refractory hypotension (RR 0.35, 95% CI 0.19 to 0.65; RD -0.47, 95% CI - 0.68 to - 0.26; NNT = 2.1, 95% CI 1.47, 3.8). There were no statistically significant effects on any other short or long-term outcome. A further two studies that have only been published in abstract form to date, may be eligible for inclusion in a future update of this review.
AUTHORS' CONCLUSIONS: Hydrocortisone may be as effective as dopamine when used as a primary treatment for hypotension. But the long term safety data on the use of hydrocortisone in this manner is unknown.Steroids are effective in treatment of refractory hypotension in preterm infants without an increase in short term adverse consequences. However, long term safety or benefit data is lacking. With long term benefit or safety data lacking steroids cannot be recommended routinely for the treatment of hypotension in preterm infants.
Hafis Ibrahim; Ian P Sinha; Nimish V Subhedar
Related Documents :
21263399 - Placenta previa percreta with bladder invasion.
24054169 - Mother-infant inpatient units.
22834719 - Refining neurobehavioral assessment of the high-risk infant using the nicu network neur...
22393339 - Assessment of primitive reflexes in high-risk newborns.
24709429 - Fluoride concentration in commonly consumed infant juices.
1747079 - Distribution of expired air in carry cots--a possible explanation for some sudden infan...
7919589 - Recent advances in the understanding and management of stable and unstable angina pecto...
18719619 - Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during b...
23493169 - Preservation of the metabolic rate of oxygen in preterm infants during indomethacin the...
Publication Detail:
Type:  Journal Article; Meta-Analysis; Review     Date:  2011-12-07
Journal Detail:
Title:  The Cochrane database of systematic reviews     Volume:  -     ISSN:  1469-493X     ISO Abbreviation:  Cochrane Database Syst Rev     Publication Date:  2011  
Date Detail:
Created Date:  2011-12-13     Completed Date:  2012-01-30     Revised Date:  2013-06-28    
Medline Journal Info:
Nlm Unique ID:  100909747     Medline TA:  Cochrane Database Syst Rev     Country:  England    
Other Details:
Languages:  eng     Pagination:  CD003662     Citation Subset:  IM    
Neonatal Intensive Care Unit, Liverpool Women's Hospital, Liverpool, UK, L8 7SS.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenal Cortex Hormones / therapeutic use*
Dexamethasone / therapeutic use
Dopamine / therapeutic use
Hydrocortisone / therapeutic use
Hypotension / drug therapy*
Infant, Newborn
Infant, Premature
Infant, Premature, Diseases / drug therapy*
Randomized Controlled Trials as Topic
Reg. No./Substance:
0/Adrenal Cortex Hormones; 50-02-2/Dexamethasone; 50-23-7/Hydrocortisone
Update Of:
Cochrane Database Syst Rev. 2007;(1):CD003662   [PMID:  17253493 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Heroin maintenance for chronic heroin-dependent individuals.
Next Document:  Auditory integration training and other sound therapies for autism spectrum disorders (ASD).